论文部分内容阅读
目的:分析在偏头痛的治疗中选用尼莫地平联合镇痛宁胶囊的药效。方法:选取偏头痛病患65例,遵从自愿选药原则入组,一组联合服用两种药,尼莫地平和镇痛宁胶囊,均分3次服用,每次分别送服0.4g、4粒,33例患者自愿为一组成员;二组仅服用一种药即尼莫地平,服用方法和剂量与一组相同(0.4g),32例患者自愿为二组成员,对比两组服药1个疗程取得的疗效,以分析联合服用两种药的药效。结果:一组有31例明显好转,好转率为93.9%,显效率为48.5%(16例),二组有22例明显好转,好转率为68.8%,显效率为21.9%(7例),药效差异具有统计学意义(P<0.05)。结论:在偏头痛的治疗中选用尼莫地平联合镇痛宁胶囊,是一种将西药制剂联合中药制剂使用的治疗方法,与仅使用西药制剂(尼莫地平)的药效相比,更为理想。
OBJECTIVE: To analyze the efficacy of nimodipine and xitongning capsule in the treatment of migraine. Methods: Sixty-five patients with migraine were enrolled in the study. Patients were enrolled in the study according to the principle of voluntary drug selection. One group took two drugs, nimodipine and analgesic capsules, each taking 3 doses of 0.4g, 4 Tablets, 33 patients volunteered as a group; two groups taking only one drug that is nimodipine, taking a dose and the same dose (0.4g), 32 patients volunteered to be two groups of patients, compared to two groups taking 1 The efficacy of a course of treatment to analyze the combined effect of two drugs. Results: In one group, 31 cases improved significantly, the improvement rate was 93.9%, the effective rate was 48.5% (16 cases), the other 22 cases were significantly improved, the improvement rate was 68.8%, the effective rate was 21.9% (7 cases) Pharmacodynamic differences were statistically significant (P <0.05). Conclusion: Nimodipine and Shitongning capsules are selected in the treatment of migraine. It is a kind of treatment method that uses Western medicine combined with traditional Chinese medicine preparation. Compared with the efficacy of western medicine preparation (nimodipine) alone, ideal.